Insights into Pharmacological Activities of Nicotine and 6-Hydroxy-L-nicotine, a Bacterial Nicotine Derivative: A Systematic Review

Biomolecules. 2023 Dec 23;14(1):23. doi: 10.3390/biom14010023.

Abstract

The purported cognitive benefits associated with nicotine and its metabolites in the brain are a matter of debate. In this review, the impact of the pharmacologically active metabolite of a nicotine derivative produced by bacteria named 6-hydroxy-L-nicotine (6HLN) on memory, oxidative stress, and the activity of the cholinergic system in the brain was examined. A search in the PubMed, Science Direct, Web of Science, and Google Scholar databases, limiting entries to those published between 1992 and 2023, was conducted. The search focused specifically on articles about nicotine metabolites, memory, oxidative stress, and cholinergic system activity, as well as enzymes or pathways related to nicotine degradation in bacteria. The preliminary search resulted in 696 articles, and following the application of exclusion criteria, 212 articles were deemed eligible for inclusion. This review focuses on experimental studies supporting nicotine catabolism in bacteria, and the chemical and pharmacological activities of nicotine and its metabolite 6HLN.

Keywords: 6-hydroxy-L-nicotine; bacteria; degradation; memory; metabolite; nicotine; oxidative stress.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Bacteria*
  • Brain
  • Cholinergic Agents
  • Databases, Factual
  • Humans
  • Nicotine* / pharmacology

Substances

  • Cholinergic Agents
  • Nicotine